Article
Elevated circulating levels of phenylacetylglutamine in stroke patients with T2D are linked to specific gut microbiota
2022-06-22
Abstract excerpt
<title>Abstract</title> <p>Objective Type 2 diabetes (T2D) aggravates the injury of ischemic stroke (IS). The alterations of gut microbiota and its metabolite phenylacetylglutamine (PAGln) levels in stroke patients with T2D remain unclear. Therefore, our study aimed to explore the differences in gut microbiota and its metabolite PAGln between IS patients with and without T2D. Methods In our study, 35 IS with T2...
Topics
Open a Topic to create a Post that cites this publication.
- Autophagy in Disease and Therapy
- Botulinum Toxin and Related Neurological Disorders
- Dementia and Cognitive Impairment Research
- Diet and metabolism studies
- Gut microbiota and health
- Mycobacterium research and diagnosis
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
Identifiers and source
- Literature Corpus work
- 666cad77-69f2-5656-a886-04cb665e6660
- DOI
- 10.21203/rs.3.rs-1245321/v2
